PREVENTion and treatment of incontinence-associated dermatitis through a codesigned manual (PREVENT-IAD): a study protocol for a feasibility cluster randomised controlled trial with a nested process evaluation
PREVENTion and treatment of incontinence-associated dermatitis through a codesigned manual (PREVENT-IAD): a study protocol for a feasibility cluster randomised controlled trial with a nested process evaluation
Introduction: incontinence is commonly experienced by adults who receive care support in a residential facility or in their own home. These individuals are at risk of developing incontinence-associated dermatitis (IAD), which is caused by prolonged and repeated exposure of the skin to urine or faeces. An IAD manual was developed providing an evidence-based clinical algorithm and an e-learning training programme for the prevention and treatment of IAD. The aim of the study is to establish the feasibility of conducting a definitive trial to examine the clinical and cost-effectiveness of the IAD manual. The objectives are to assess recruitment and attrition rates, acceptability of the IAD manual and intervention fidelity.
Methods and analysis: feasibility cluster randomised controlled trial will be conducted in residential nursing homes and in the homes of people receiving formal care support in London and Hampshire, England. A total of six clusters including n=248 participants who are incontinent of urine, or faeces will be included. At each intervention site, care staff will be trained to implement the IAD manual over a 6-month period. Quantitative outcomes include IAD incidence and severity, IAD-related pain, satisfaction with care and mental health. A qualitative evaluation of care staff and care receivers' experiences of participation will be conducted. Rates and proportions of each feasibility outcome will be described informing the sample size estimation for a definitive cluster randomised controlled trial. A thematic analysis of the qualitative data will be guided by a logic model detailing potential factors impacting on both the study methodology and adoption of the IAD manual into routine care.
Ethics and dissemination: the study received the approval of the Queens Square Ethics Committee Health Research Authority 23/LO/036, (Project ID 296167). Results will be disseminated through peer-reviewed open-access journals and international conferences TRIAL REGISTRATION NUMBER: ISRCTN70866724.
Humans, Dermatitis/prevention & control, England, Feasibility Studies, Fecal Incontinence/therapy, Nursing Homes, Randomized Controlled Trials as Topic, Urinary Incontinence/therapy
e092338
Woodward, Sue
fcf00367-04c2-4e26-adee-c86d30f96035
Graham, Tanya
8d1f961d-d8d9-48cb-83f3-ddeb8cf1746d
Sooriah, Sangeeta
c1791deb-3d77-4f33-bd22-b7938de80311
Beeckman, Dimitri
1ead183b-0e82-4b3f-864b-8dfc2e58de3e
Chatterton, Chris
74ba06b6-ba72-440c-adc4-3d8d8c404a0e
Fader, Mandy
c318f942-2ddb-462a-9183-8b678faf7277
Fiorentino, Francesca
e7bed6cb-dccf-437d-b58d-844bfc4e280a
Fitzpatrick, Joanne M.
b356ea3e-95de-49dc-96c0-45fbabd51d03
Harris, Ruth
1e848808-be89-4f63-a62b-41ec65b8c82f
Kottner, Jan
50d0d629-8765-445b-b21d-11dbc4e6e504
Norton, Christine
1c77c449-6a2a-4d2c-a600-197faa925fed
Worsley, Peter
6d33aee3-ef43-468d-aef6-86d190de6756
23 December 2024
Woodward, Sue
fcf00367-04c2-4e26-adee-c86d30f96035
Graham, Tanya
8d1f961d-d8d9-48cb-83f3-ddeb8cf1746d
Sooriah, Sangeeta
c1791deb-3d77-4f33-bd22-b7938de80311
Beeckman, Dimitri
1ead183b-0e82-4b3f-864b-8dfc2e58de3e
Chatterton, Chris
74ba06b6-ba72-440c-adc4-3d8d8c404a0e
Fader, Mandy
c318f942-2ddb-462a-9183-8b678faf7277
Fiorentino, Francesca
e7bed6cb-dccf-437d-b58d-844bfc4e280a
Fitzpatrick, Joanne M.
b356ea3e-95de-49dc-96c0-45fbabd51d03
Harris, Ruth
1e848808-be89-4f63-a62b-41ec65b8c82f
Kottner, Jan
50d0d629-8765-445b-b21d-11dbc4e6e504
Norton, Christine
1c77c449-6a2a-4d2c-a600-197faa925fed
Worsley, Peter
6d33aee3-ef43-468d-aef6-86d190de6756
Woodward, Sue, Graham, Tanya, Sooriah, Sangeeta, Beeckman, Dimitri, Chatterton, Chris, Fader, Mandy, Fiorentino, Francesca, Fitzpatrick, Joanne M., Harris, Ruth, Kottner, Jan, Norton, Christine and Worsley, Peter
(2024)
PREVENTion and treatment of incontinence-associated dermatitis through a codesigned manual (PREVENT-IAD): a study protocol for a feasibility cluster randomised controlled trial with a nested process evaluation.
BMJ Open, 14 (12), .
(doi:10.1136/bmjopen-2024-092338).
Abstract
Introduction: incontinence is commonly experienced by adults who receive care support in a residential facility or in their own home. These individuals are at risk of developing incontinence-associated dermatitis (IAD), which is caused by prolonged and repeated exposure of the skin to urine or faeces. An IAD manual was developed providing an evidence-based clinical algorithm and an e-learning training programme for the prevention and treatment of IAD. The aim of the study is to establish the feasibility of conducting a definitive trial to examine the clinical and cost-effectiveness of the IAD manual. The objectives are to assess recruitment and attrition rates, acceptability of the IAD manual and intervention fidelity.
Methods and analysis: feasibility cluster randomised controlled trial will be conducted in residential nursing homes and in the homes of people receiving formal care support in London and Hampshire, England. A total of six clusters including n=248 participants who are incontinent of urine, or faeces will be included. At each intervention site, care staff will be trained to implement the IAD manual over a 6-month period. Quantitative outcomes include IAD incidence and severity, IAD-related pain, satisfaction with care and mental health. A qualitative evaluation of care staff and care receivers' experiences of participation will be conducted. Rates and proportions of each feasibility outcome will be described informing the sample size estimation for a definitive cluster randomised controlled trial. A thematic analysis of the qualitative data will be guided by a logic model detailing potential factors impacting on both the study methodology and adoption of the IAD manual into routine care.
Ethics and dissemination: the study received the approval of the Queens Square Ethics Committee Health Research Authority 23/LO/036, (Project ID 296167). Results will be disseminated through peer-reviewed open-access journals and international conferences TRIAL REGISTRATION NUMBER: ISRCTN70866724.
Text
e092338.full
- Version of Record
More information
Accepted/In Press date: 8 November 2024
Published date: 23 December 2024
Keywords:
Humans, Dermatitis/prevention & control, England, Feasibility Studies, Fecal Incontinence/therapy, Nursing Homes, Randomized Controlled Trials as Topic, Urinary Incontinence/therapy
Identifiers
Local EPrints ID: 497754
URI: http://eprints.soton.ac.uk/id/eprint/497754
ISSN: 2044-6055
PURE UUID: d9f30ba3-8395-4791-a51e-d13f7d7f7473
Catalogue record
Date deposited: 30 Jan 2025 17:52
Last modified: 03 Jul 2025 01:53
Export record
Altmetrics
Contributors
Author:
Sue Woodward
Author:
Tanya Graham
Author:
Sangeeta Sooriah
Author:
Dimitri Beeckman
Author:
Chris Chatterton
Author:
Francesca Fiorentino
Author:
Joanne M. Fitzpatrick
Author:
Ruth Harris
Author:
Jan Kottner
Author:
Christine Norton
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics